Several reports have shown marked upregulation of SLC6A14 in many types of solid tumors, including colon cancer [68,69], cervical cancer [70,71], estrogen receptor-positive breast cancer [72,73,74], and pancreatic cancer [75,76,77,78,79,80]. Here, ESR1 is linked to breast cancer.